
NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
U.S. Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
CINCINNATI, Ohio – December 15, 2025 – LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their…
US Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
CINCINNATI, Ohio – December 15, 2025 – LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their…
S6E12: ATTAIN in Practice: Translating Data Into Lipid Decisions
In this episode of Lipid Insights, host Dr. Peter H. Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN Study and what it means for…
The Lipid Panel – Untangling Triglycerides
Expert Guidelines At-A-Glance: Acute Pancreatitis & Elevated Triglycerides
Expert Guidelines At-A-Glance: Acute Pancreatitis & Elevated Triglycerides
S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts
Join host Peter H. Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is…
S6E10: Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease
Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the…